More on TBPH
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $16.93 |
|
|||
| Open | $16.95 | ||||
| 52 Wk High | $38.92 | ||||
| 52 Wk Low | $12.87 | ||||
| Day High | $16.98 | ||||
| Day Low | $16.89 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 777,048 | ||||
- Form 4 Theravance Biopharma, For: Jul 06 Filed by: Samaha Eli
- H.C. Wainwright Downgrades Theravance Biopharma (TBPH) to Neutral
- Form 4 Theravance Biopharma, For: Jun 29 Filed by: Samaha Eli
- BTIG Downgrades Theravance Biopharma (TBPH) to Neutral
- Jones Trading Downgrades Theravance Biopharma (TBPH) to Hold
- Form DEFA14A Theravance Biopharma,
- Form 8-K Theravance Biopharma, For: Jun 28
- Zymeworks to acquire Theravance Biopharma for $17 per share
- Zymeworks to buy Theravance Biopharma for $17 per share
- THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT
Entities mentioned with TBPH
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Baupost Group | View Related Stories »
- Seth Klarman | View Related Stories »
- Show More...
